NYSE · Stocky rates: Cautious

Becton, Dickinson and Company D (BDXA)

$59.24 ▼ -2.24% as of 6 Aug, 01:57
43
/ 100
Neutral

What Stocky thinks

Cautious. Becton Dickinson's mediocre compounder scores (33.8 Growth, 34 Value) reflect mature medical-device dynamics with mid-single-digit revenue growth and modest returns on capital. Leadership alignment (59/100) shows moderate insider commitment, but the Vulnerability Index (50/100) signals reliance on financial reserves rather than durable competitive advantages—regulatory dependency and customer concentration remain structural headwinds.

Compounder Score
34/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
59/100
Founder-led, insider ownership, capital allocation history.
Vulnerability
50/100
Downside resilience — customer concentration, supply chain, refinancing risk.
Value Score
34/100
Valuation vs peers and history — is this a good price to pay?

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for Becton, Dickinson and Company D:

43
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 43/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

59
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

50
RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

Becton, Dickinson and Company D (BDXA) — frequently asked

Is Becton, Dickinson and Company D (BDXA) a good investment right now?

Stocky rates Becton, Dickinson and Company D (BDXA) at 43/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. Becton Dickinson's mediocre compounder scores (33.8 Growth, 34 Value) reflect mature medical-device dynamics with mid-single-digit revenue growth and modest returns on capital. Leadership alignment (59/100) shows moderate insi

What is BDXA's Stocky Verdict?

BDXA's current Stocky Verdict is 43/100, placing it in the "Cautious" band. This composite combines a 34/100 Compounder score, 59/100 Leadership, Moat rating, and analyst signal.

Does Becton, Dickinson and Company D have a competitive moat?

Stocky hasn't finalised a Moat Score for Becton, Dickinson and Company D yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is Becton, Dickinson and Company D's leadership aligned with shareholders?

Becton, Dickinson and Company D scores 59/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to BDXA?

Becton, Dickinson and Company D's Vulnerability Profile scores 50/100 (higher = more resilient). The profile flags customer concentration, supply chain, refinancing walls and regulatory risks specific to Becton, Dickinson and Company D.

This is just the surface. See the whole picture on Becton, Dickinson and Company D.

Sign up free and unlock the full analysis on BDXA — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering BDXA — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for BDXA.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how BDXA changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to BDXA?" · "Is BDXA overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
43
/ 100 · Neutral

Or jump straight to the interactive dashboard for BDXA in the app.